Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Platt OS
Diagnosing MPNST in NF1 patients
In a statement today, Tummino said of the second Lilly partnership: We are excited to collaborate with Lilly on another program, combining our discovery capabilities with their metabolic disease expertise to bring a much-needed new treatment to people with obesity and make a meaningful difference in their lives. $55M upfront Lilly agreed to pay Nimbus $55 million in upfront and near-term payments tied to achieving milestones
Unlike topical treatments or fillers, Klow works from within the body to repair, restore, and rejuvenate skin naturally
Developed by Eli Lilly, the same pharmaceutical giant behind tirzepatide (better known as Mounjaro and Zepbound), this new contender is generating buzz for its potential to help people lose more weight, faster
US$ 27.48
US$ 23.14
US$ 26.19
US$ 23.75
US$ 28.44
US$ 22.82
